Cargando…
Comparative study of the safety and efficacy of SMOFlipid vs non SMOFlipid as TPN for liver transplantation
BACKGROUND: Liver transplantation (LT) is one of the widely recognised and leading treatments for end-stage liver disease. Nutrition impacts its success. Total parenteral nutrition (TPN) is usually prescribed for patients recommended prolonged fasting after LT. The supplement of SMOFlipid (soybean o...
Autores principales: | Wu, Mei-Yun, Kuo, Sheng-Chih, Chuang, Su-Fen, Yeh, Cheng-Hsi, Yin, Shih-Min, Li, Wei-Feng, Wang, Hung-Jen, Chen, Chao-Long, Wang, Chih-Chi, Lin, Chih-Che |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905355/ https://www.ncbi.nlm.nih.gov/pubmed/33664940 http://dx.doi.org/10.1016/j.amsu.2021.01.042 |
Ejemplares similares
-
Smoflipid Is Better Than Lipofundin for Long-Term Neurodevelopmental Outcomes in Preterm Infants
por: Chen, I-Lun, et al.
Publicado: (2021) -
SMOFlipid Impact on Growth and Neonatal Morbidities in Very Preterm Infants
por: Asfour, Suzan S., et al.
Publicado: (2022) -
Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022) -
Current Evidence for the Use of Smoflipid® Emulsion in Critical Care Patients for Parenteral Nutrition
por: Leguina-Ruzzi, Alberto A., et al.
Publicado: (2018) -
Discrepancies in Lipemia Interference Between Endogenous Lipemic Samples and Smoflipid(®)-Supplemented Samples
por: Fernández-Prendes, Carla, et al.
Publicado: (2023)